Everolimus discontinuation
Everolimus discontinuation has been studied in 1 paper since 2026: none in people yet; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Feb 17, 2026: “Out of the fire into the frying pan: Everolimus-induced organizing pneumonia in a patient with pancreatic neuroendocrine tumor”.
1 paper studies it1 findingUpdated
See all 1 papers on everolimus discontinuation
At a glance
The findings reach people, from one lab or study. 1 lab.
“Her respiratory symptoms and oxygen requirements improved after cessation of everolimus.”
- 1 lab
What did studies of everolimus discontinuation find?
1Studies of everolimus discontinuation measured 1 outcome; the most studied are respiratory symptoms (1 study).
Respiratory symptoms
downin humans1
1 study
Respiratory symptoms
downin humans1
Everolimus discontinuation is linked with lower respiratory symptoms in humans (organizing pneumonia in a patient with pancreatic neuroendocrine tumor).
“Her respiratory symptoms and oxygen requirements improved after cessation of everolimus.”
Humansorganizing pneumonia in a patient with pancreatic neuroendocrine tumorlungfemalesn = 1
Respiratory medicine case reports